Chronos Dental partners with ICG to accelerate growth in France and expand across Europe

ICG 3D image representative of biotechnology
"We are delighted to partner with Mathieu, Manuel and the dental technician shareholders of Chronos Dental on this new phase of growth", says Laurent Catry, Managing Director, ICG Europe Mid-Market.

ICG, the global alternative asset manager, today announced that its Europe Mid-Market team has entered into a partnership with Chronos Dental (“the Group”), a leading dental laboratory group in France, to support the Group’s next phase of growth.

Founded by Mathieu Carton and Manuel Moustaid, Chronos Dental has established itself as a leading player in the French dental prosthetics market. The Group brings together 35 dental laboratories and over 600 employees, serving a broad base of more than 5,000 dentists. Its laboratories offer a full range of dental prostheses, including crowns, bridges, implant-supported and removable prostheses, together with associated digital and training services to dentists.

Since its creation, building a shared ownership model alongside laboratory founders has been at the core of the Group’s DNA, making Chronos Dental the only platform in the industry controlled by its founders and dental technicians. The complementary expertise of its 35 laboratories enables the Group to address the full spectrum of dentists’ needs across all price points. All laboratories in the network benefit from increasingly digitalised production processes and continuously rising quality standards.

The Group operates in a resilient and growing European dental prostheses market, underpinned by long-term structural trends including an ageing population, improved access to dental care and rising aesthetic demand, as well as the continued digitalisation of the value chain.

The partnership will see ICG provide a bespoke financing solution to support the Group’s buy-and-build strategy in France and its expansion across other European markets. The Group’s co-founders and dental technician shareholders will retain control, preserving the entrepreneurial, owner-led culture that has underpinned its success to date. With ICG’s backing, Chronos Dental will pursue consolidation opportunities in a highly fragmented market, while continuing to invest in the digitalisation of its production processes, the deployment of its proprietary digital laboratory management tools across its network, and the scaling of its organisation to support this growth.

Carton, Co-Founder and CEO of Chronos Dental, commented:

This partnership is an important milestone for Chronos Dental and a strong recognition of the platform we have built. We were looking for a long-term partner with a European footprint and the financial capacity to support our next phase of growth, without compromising the founder- and technician-led model that Manuel and I have created. ICG’s entrepreneurial approach was a natural fit for us. Together, we will accelerate our development in France and embark on our European expansion, while keeping technology and service quality at the centre of our value proposition to dentists.

Laurent Catry, Managing Director, ICG Europe Mid-Market,
Laurent Catry, Managing Director, ICG Europe Mid-Market

Laurent Catry, Managing Director, ICG Europe Mid-Market, added:

We are delighted to partner with Mathieu, Manuel and the dental technician shareholders of Chronos Dental on this new phase of growth. Chronos Dental has many of the characteristics we look for in our partnerships: ambitious founders with a strong alignment of interests, a distinctive and owner-led model, and a resilient market with significant potential for further consolidation. We have been impressed by the Group’s ability to integrate and develop its network while maintaining strong growth, and believe its differentiated positioning makes it a partner of choice for laboratories and dentists across Europe. We look forward to supporting the team as they execute their strategy.

The terms of the transaction are undisclosed.

– Ends –

Notes to Editors

ICG was advised by Proskauer (legal), BCG (commercial), PwC (financial) and KPMG (legal, tax, social) and Natixis Partners. Chronos Dental was advised by Rothschild & Co (M&A), Goodwin and Jeausserand-Audouard (legal), Ollyns (financing), 8Advisory (financial), Arsène Taxand (tax) and LEK (commercial).

About ICG

ICG (LSE: ICG) is a global alternative asset manager with $145bn* in AUM and more than three decades of experience generating attractive returns. We operate from over 20 locations globally and invest our clients’ capital across Structured Capital; Private Equity Secondaries; Private Debt; Liquid Credit; and Real Assets. Our exceptional people originate differentiated opportunities, invest responsibly, and deliver long-term value. We partner with management teams, founders, and business owners in a creative and solutions-focused approach, supporting them with our expertise and flexible capital. For more information visit our website and follow us on LinkedIn.

*As at 30 September 2026.

About Chronos Dental

Founded by Mathieu Carton and Manuel Moustaid, Chronos Dental is a leading dental laboratory group in France, bringing together 35 laboratories and over 600 employees serving more than 5,000 dentists across the country. The only platform in the industry controlled by its founders and dental technicians, the Group offers a full range of fixed, implant-supported, and removable prostheses, as well as digital and training services. For more information, visit chronos-dental.com.

For further information please contact:

Fiona Laffan

Global Head of Corporate Affairs

+44 20 3545 1510
[email protected]

Maisie Le Masurier
Corporate Communications

+44 20 3545 1624
[email protected]